A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology
Background: The current model of clinical drug development in oncology displays major limitations due to a high attrition rate in patient enrollment in early phase trials and a high failure rate of drugs in phase III studies. Objective: Integrating transcriptomics for selection of patients has the p...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2023-03-01
|
| Col·lecció: | Therapeutic Advances in Medical Oncology |
| Accés en línia: | https://doi.org/10.1177/17588359231156382 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|